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Abstract
Background: The concept of total mesorectal excision
has revolutionised rectal cancer surgery. TME reduces
the  rate  of  local  recurrence  and  tumour  associated
mortality. However, in clinical trials only 50% of the
removed rectal tumours have an optimal TME quality.
Patients: During a period of 36 months we performed
103 rectal resections. The majority of patients (76%;
78/103) received an anterior resection. The remaining
patients underwent either abdominoperineal resection
(16%; 17/103), Hartmann`s procedure (6%; 6/103) or
colectomy (2%; 2/103).
Results: In 90% (93/103) TME quality control could
be performed. 99% (92/93) of resected tumours had
optimal TME quality. In 1% (1/93) the mesorectum
was nearly complete. none of the removed tumours
had an incomplete mesorectum. In 98% (91/93) the
circumferential resection margin was negative. Major
surgical complications occurred in 17% (18/103). 5%
(4/78) of patients with anterior resection had anasto-
motic leakage. 17% (17/103) developed wound infec-
tions. Mortality after elective surgery was 4% (4/95).
Conclusion: Optimal  TME  quality  results  can  be
achieved in all stages of rectal cancer with a rate of
morbidity  and  mortality  comparable  to  the  results
from the literature. Future studies should evaluate out-
come and local recurrence in accordance to the degree
of TME quality.
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BackgROunD
The concept of total mesorectal excision (TME) has
been the most important development in rectal cancer
surgery during the last two decades. after the intro-
duction of TME the rate of local recurrence could be
dramatically  reduced  [1].  Even  without  curative  ap-
proach, local recurrence was reduced to 6-12% and 5-
year survival rate improved to 53-87% [2-4]. However,
it is noteworthy, that the excellent results of a local re-
currence  rate  of  less  than  5%  without  neoadjuvant
treatment  modalities  as  reported  by  Heald  have  not
been reached by the majority of rectal surgeons [1]. 
TME quality is often referred to the graduation of
the M.E.R.c.u.R.y. study that was based on the classi-
fication of malignant gastrointestinal tumours [5].
The protocol differentiates between three levels of
surgical quality ranging from complete (M.E.R.c.u.R.y.
I.ﾰ)to incomplete TME (M.E.R.c.u.R.y. III.ﾰ) (Table 1).
a  recent  multicentre  trial  analysed  the  benefit  of
preoperative radiation before TME surgery. Surgeons
were trained in TME surgery before participating in
the study. nevertheless only 50% of resected speci-
mens had an optimal TME quality [6, 7]. If optimal
TME-quality could be achieved in a controlled scien-
tific  trial  in  only  50%  of  patients,  serious  concern
should arise about the TME quality in the absence of
pathological quality control.
although  most  centres  claim  performing  TME
surgery, the literature evaluating TME quality is scarce.
To  close  this  gap  we  present  our  results  of  TME
surgery after the introduction of quality controls for
rectal cancer surgery at our centre in 2004.
PaTIEnTS anD METHODS
During a period of 36 months, between January 2004
and December 2006, 103 patients underwent surgical
resection  for  rectal  cancer  at  the  Department  of
Surgery, St. Josef Hospital, Ruhr- university Bochum,
germany.  Sixty  percent  (62/103)  were  male,  40%
(41/103) were female. Mean age was 68.5 years, with a
range from 38 to 95 years.
Preoperative  staging  included  complete  colono  -
scopy or barium enema, abdominal cT scan and chest
X-ray. Endorectal ultrasound was performed in 76%
(78/103)  of  patients.  MRI  was  not  routinely  per-
formed. The decision about neoadjuvant therapy was
based  on  weekly  multidisciplinary  tumour  board  re-
views. In 29% (30/103) neoadjuvant therapy was per-
formed  prior  to  operation,  including  22%  (23/103)
short term radiation (5x5 gy) and 7% (7/103) long
term chemoradiation (50 gy). In-hospital death was
defined as death within 30 postoperative days.
TME SuRgERy
all patients underwent surgery according to the princi-
ples of TME. after anterior resection, reconstruction
was achieved via stapled anastomosis (29mm or 31mm
stapler) or hand sutured coloanal anastomosis. Recon-
struction included the formation of a colonic pouch
by performing a transverse coloplasty whenever possi-
ble [8]. 
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Histopathological examination was performed accord-
ing to the protocol of Quirke et al. [9]. The quality of
the surgical resections was first judged by macroscopic
assessment of the specimens’ surface. after fixation,
staining and slicing, the completeness of the mesorec-
tum was judged by microscopic investigation. Tumour
type, T-Stage and n-Stage were documented for the
purposes  of  the  study.  Further  recording  included
proximal, distal and circumferential resection margins,
tumour size and histopathological grading. The quality
of the mesorectum was then determined according to




ninetynine percent (102/103) of the removed tumours
were adenocarcionomas of the rectum. One patient with
malignant melanoma of the anus had abdomino  perineal
resection. 8% (8/103) of patients needed urgent surgery
secondary to ileus (3%; 3/103) or perforation of rectal
carcinoma (5%; 5/103). In 76% (78/103) an anterior
resection was performed, 6% underwent (6/103) Hart-
mann`s operation and 2% (2/103) had a col  ectomy. In
16% (17/103) of cases an abdominoperineal resection
was performed. These patients either had local recur-
rence of rectal cancer, a tumour less than 2 cm from
the anal verge, sphincter infiltration, sphincter insuffi-
ciency or malignant melanoma of the anus. 
Major  surgical  complications  occurred  in  17%
(18/103)  of  patients,  including  anastomotic  leakage,
wound dehiscence, intra-abdominal abscess formation,
postoperative  haemorrhage  and  failure  of  the  rectal
remnant  after  Hartmann’  operation.  Major  general
complications occurred in 7% (7/103) including pneu-
monia,  stroke  and  myocardial  infarction  (Table  2).
Mortality  after  elective  operations  was  4%  (4/95),
while patients undergoing urgent surgery had a mor-
tality rate of 38% (3/8), p= 0.026.
HISTOPaTHOlOgIcal RESulTS
In 90% (93/103) an evaluation of the quality of the
mesorectum  was  possible.  In  10%  (10/103)  quality
analysis  was  impossible.  7  patients  had  local  recur-
rence of rectal cancer and had already had rectal resec-
tion during prior surgery. 3 patients were part of an-
other study which required immediate opening of the
removed rectum for the collection of unfixed tumour
biopsies from the removed tumour.
The  analysis  showed  a  complete  mesorectum
(M.E.R.c.u.R.y. Iﾰ) in 99% (92/93) of removed tu-
mours. In 1% (1/93) the mesorectum was nearly com-
plete (M.E.R.c.u.R.y. IIﾰ), and none (0/93) of the re-
moved  tumours  had  an  incomplete  mesorectum
(M.E.R.c.u.R.y.  IIIﾰ).  Macroscopic  TME  quality  is
shown in Figure 1.
In 98% (91/93) the circumferential resection margin
was negative, showing no tumour infiltration at least 2
millimeters away from the lateral resection margin.
One patient requiring urgent surgery for perforated
rectal cancer (uIcc tumour stage IIIc) had involvement
of the lateral resection margin. The other patient with
lateral resection margin involvement was operated after
long term chemoradiation (uIcc tumour stage IIIb).
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Table 1. Quality of mesorectal excision according to M.E.R.c.u.R.y. criteria [5].
M.E.R.c.u.R.y. Iﾰ complete Mesorectum Smooth, intact
Defects not deeper than 5mm
coning no coning
cRM Smooth, regular
M.E.R.c.u.R.y. IIﾰ nearly complete Mesorectum Moderate bulk, irregular
Defects no visible muscularis propria
coning Moderate
cRM Irregular
M.E.R.c.u.R.y. IIIﾰ Incomplete Mesorectum little bulk
Defects Down onto muscularis propria
coning yes
cRM Irregular
Table 2. Major complications after surgery for rectal cancer.
Surgical complications anastomotic leakage 4 5%
(n=18) Wound dehiscence 4 4%
Intraabdominal abscess 4 4%
Bleeding 2 2%
Hartmann`s stump leakage 3 50%
ureter injury 1 1%
general complications Pneumonia 5 5%
(n=7) Stroke 1 1%
Myocardial infarction 1 1%
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have advanced rectal cancer (> T2 or n+). Of those,
61% (31/51) received neoadjuvant radiation, while 39%
(20/51) underwent operation without preoperative ra-
diation. The reasons for primary operation without ra-
diation in advanced stages of rectal cancer included re-
currence  of  rectal  cancer  (7%;  7/103),  suspected
metastatic  disease  (9%;  9/103),  urgent  surgery  (8%;
8/103), advanced age (2%; 2/103), severe co-morbidi-
ties (2%; 2/103), incompliance (1%; 1/103), other ma-
lignancy (1%; 1/103) or combination of these. 
The mean number of lymph nodes removed during
the operation was 19 (range 4-47). Sixtysix percent of
the removed tumours (68/103) had moderate differen-
tiation,  17%  (18/103)  good  differentiation  and  9%
(9/103) poor differentiation, while in 1% (1/103) an
un  differentiated tumour was found. In 7% (7/103) of
cases  grading  was  not  possible.  Distant  metastases
were pre  sent in 9% (9/103), including 6 patients with
hepatic metastases, 1 patient with pulmonary and he-
patic meta  stases and two patients with metastases to-
wards other organs. In 91% (94/103) patients had no
distant metastases.
In 2% (2/103) of the cases a macroscopic residual
tumour (R2) was present in the pelvis after resection.
One of those patients had also a liver metastasis. In
98%  (101/103)  no  residual  tumour  (R0)  was  left  in
situ.  There  was  no  case  of  microscopic  residual  tu-
mour (R1). 5% (5/103) of the patients had overall R2
resection because of hepatic or pulmonary metastasis,
while 2% (2/103) of the patients underwent simultane-
ous hepatic tumour resection resulting in R0 situ  ation.
until May 2009 there has been one proven local re-
currence. In november 2005 this patient had palliative
rectal resection for a pT3b, pn2 (8/22), l1, v1, Pn1,
pM1  (hepatic  and  pulmonary),  g3,  uIcc-stage  Iv
rectal cancer. The rectal cancer recurrence was diag-
nosed in May 2007.
DIScuSSIOn
The prognosis of rectal cancer depends principally on
tumour stage at the time of diagnosis, while local re-
currence  depends  rather  on  surgical  technique.  In
studies on colorectal cancer, survival is most impor-
tant, but trials on rectal cancer also focus on local re-
currence since local control also correlates with sur-
vival [10]. conventional resections for rectal cancer re-
sult in recurrence rates between 20% and 40% [11].
Patients  receiving  preoperative  radiotherapy  before
conventional resection for rectal cancer still have re-
currence rates between 28% and 37% [12,13]. 
TME has been shown to result in reduced local re-
currence and better overall survival [1]. The rate of lo-
cal recurrence is directly related to the technique of
rectal cancer excision, which makes surgical technique
the most important factor for patients’ outcome. al-
though  TME  is  accepted  in  western  countries  as  a
standard principle of surgical treatment for rectal can-
cer the rate of local recurrence without radiotherapy
varies between 3% and 18% [1,14].
kapiteijn and his group could show that short term
preoperative radiotherapy reduced the rate of local re-
currence [6]. This analysis suggests that radiotherapy is
the key for the reduction of local recurrence. But the
fact that best results for rectal cancer surgery were re-
ported without radiotherapy by Heald who originally
introduced  the  principle  of  TME  makes  it  obvious
that the surgeon plays a crucial rule for patients` prog-
nosis. at a mean follow up of 4,2 years after curative
resection for rectal cancer Heald reported a local re-
currence rate of less than 3%. Overall survival after
115 rectal resections was 87% [1].
Two questions arise: 
1. Is the variation in local control in studies related to
the surgical quality of TME?
2. How can a good TME quality be assured?
although modern surgical treatment of colorectal
cancer implies the operative principle of TME, data
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Table 3. uIcc tumour stage; final histology (n = 103).
Histological uIcc tumour stage
n = 103 %
Stage I 34 33%
Stage IIa 19 18%
Stage IIb 5 5%
Stage IIIa 8 8%
Stage IIIb 13 13%
Stage IIIc 15 14%
Stage Iv 9 9%
Fig. 1. Macroscopic high TME quality of an un-
fixed rectal resection specimen showing the in-
tact mesorectum without defects on the surface.
The cRM is regular and smooth.
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few analyses existing have shown a high rate of in-
complete mesorectal excisions.
nagtegaal et al. analysed TME quality among a sub-
group of patients from the Dutch TME trial. They
found that only 57% had undergone complete meso  -
rectal excision (M.E.R.c.u.R.y. Iﾰ). local and distant
recurrence rate was significantly higher after incom-
plete TME [7].
These  results  were  confirmed  by  Maslekar  et  al.
They analysed local and overall recurrence in accor-
dance to the quality of TME surgery. TME quality was
optimal in 47%, 40% of patients had nearly complete
TME, while 13% had incomplete TME. local recur-
rence was related to the quality of surgery. In patients
with incomplete TME the rate of local recurrence was
41% (59% overall recurrence), in patients with nearly
complete TME the rate of local recurrence was 6%
(17% overall recurrence), while in patients with opti-
mal TME surgery the rate of local recurrence was less
than 2% (2% overall recurrence) [15].
a study from korea reported 75% optimal TME
quality (M.E.R.c.u.R.y. Iﾰ), but there were 12 patients
with positive resection margins, which makes local re-
currence likely to occur [16,17].
Hermanek and Heald also focused on the results of
the  rectal  cancer  study  from  the  netherlands.  They
showed that not the whole series of the Dutch trial
did represent a standardized TME surgery since there
was a high rate of incomplete mesorectal excisions for
resectable  rectal  cancer  [18].  The  variation  in  local
control therefore seems to be an indicator for differ-
ences in surgical quality of TME. 
More evidence for the importance of surgical quali-
ty is the difference between multicentre trials and re-
sults  from  single  institutions.  Heald’s  excellent  data
were the result of a single person applying a new tech-
nique. The analysis from the netherlands might have
compaired excellent surgical quality with poorer quali-
ty from different institutions. 
The role of the surgeon becomes even more obvi-
ous since objective analysis of the operative quality is
possible by the evaluation of the quality of TME.
Therefore  the  documentation  of  TME  quality  by
pathologists  is  essential  to  detect  deficits  in  surgical
technique. This may lead to better TME quality and
seems to be an effective tool to improve operative re-
sults [19].
In our series we could demonstrate that optimal
TME quality can be achieved with different operative
procedures in any stage of rectal carcinoma. although
we had a relatively high rate of abdominoperineal re-
sections this did not increase the rate of incomplete
TME. 
Other institutions showed that optimal TME quali-
ty can be achieved by individual training after instruc-
tion by TME trained surgeons [20]. all operations ex-
cept for urgent surgery were supervised by surgeons
being experienced in TME surgery for several years. 
During the whole study operations were performed
by  7  different  surgeons  from  our  institution.  There
were two cases of resection with residual tumour in fi-
nal histology. Both patients underwent urgent surgery
for a T4 rectal carcinoma. 
The introduction of TME surgery can be associat-
ed initially with higher rates of anastomotic leakage,
but several studies showed that these findings would
improve  during  the  routine  application  of  TME
surgery [21-23]. During the time of our study there
were 4 of 78 cases with a clinical apparent anastomot-
ic leakage. none of these patients needed a reopera-
tion. This might be a result of the routine diverting
ileostomy at our institution [24].
an  explanation  for  the  high  rate  of  Hartmann`s
stump leakage is that these were all urgent operations
for perforated rectal cancer in patients requiring high
dose  catecholamines  imparing  wound  healing.  This
fact may also be responsible for the high mortality rate
after urgent surgery. Two patients died secondary to
generalised peritonitis after Hartmannﾴs operation, the
other patient died due to excessive liver metastases af-
ter urgent colectomy. 
In our series the mean number of removed lymph
nodes was 19 (range 4-47). This result is within the
range required for rectal cancer surgery [25]. Patients
with less than 12 lymph nodes removed during the op-
eration either had a local recurrence of rectal cancer
or had undergone neoadjuvant radiation. 
apart from TME quality another marker for mas-
tery in rectal cancer surgery is the achievement of neg-
ative resection margins. Inadequate surgical resection
with lateral tumour spread will result in a local recur-
rence [9,26]. a distance of more than 1 mm from the
tumour to the border of resection is considered to be
a negative margin, although a recent analysis reported
a distance of 2 mm to be the limit [17].
There  may  be  further  discussion  about  the  exact
distance for negative resections margins, but the opti-
mal technique to obtain free resection margins is total
mesorectal excision since it has been shown that TME
achieves a negative resection margin in up to 96% of
resected specimen [20]. These results were confirmed
by nagtegaal et al. They analysed the importance of
TME to obtain free circumferential resection margins
showing that in patients with positive cRM the rate of
incomplete TME was 44% while in patients with nega-
tive cRM the rate of incomplete TME was only 11%.
Furthermore  lateral  margin  involvement  was  more
likely to occur in advanced tumour stages than in tu-
mours with positive lymph nodes. In uIcc stage III
with positive cRM secondary to incomplete mesorec-
tal excision there were significantly more patients with
lateral  margin  involvement,  by  the  primary  tumour
than by positive lymph nodes. 
In  our  series  the  rate  of  positive  circumferential
margins was 2%. compared to the results from the lit-
erature ranging between 18% and 28% of resection
margin involvement our findings reflect another effect
of optimal TME surgery [7]. 
Taken both together, the accuracy of mesorectal ex-
cision  and  the  analysis  of  circumferential  resection
margins are effective in predicting patients’ prognosis.
negative  resection  margins  unfortunately  do  not
only depend on surgical technique but on tumour size
and tumour stage at the time of operation. Thus ade-
quate staging prior to surgery is mandatory. although
radiotherapy has been shown to improve outcome for
patients with resectable rectal cancer, subgroup analy-
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fit for patients with uIcc tumour stage I or Iv in the
upper part of the rectum [6]. Therefore it is important
to  improve  selection  criteria  for  the  application  of
preoperative radiotherapy to protect patients from the
side effects of radiation without benefit [27,28]. In our
analysis we could show that optimal TME quality is
feasible in all stages of rectal cancer.
cOncluSIOn
High quality rectal cancer surgery implies the concept
of total meserectal excision. The technique of TME
can  be  learnt  under  supervision  of  specialised  sur-
geons. High quality TME  surgery can be performed
with a rate of morbidity and mortality comparable to
the results from the literature. With adequate surgical
expertise high quality TME surgery is also feasible in
advanced stages of rectal cancer. The application of a
correct TME technique also results in free circumfer-
ential resection margins. Future studies should evalu-
ate outcome and local recurrence in accordance to the
degree of TME quality. 
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